JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity

Dyson, 1998, The regulation of E2F by pRB-family proteins, Genes Dev., 12, 2245, 10.1101/gad.12.15.2245 Nevins, 1998, Toward an understanding of the functional complexity of the E2F and retinoblastoma families, Cell Growth Differ., 9, 585 Frolov, 2004, Molecular mechanisms of E2F-dependent activation and pRB-mediated repression, J. Cell Sci., 117, 2173, 10.1242/jcs.01227 Stevens, 2003, E2F and cell cycle control: a double-edged sword, Arch. Biochem. Biophys., 412, 157, 10.1016/S0003-9861(03)00054-7 Attwooll, 2004, The E2F family: specific functions and overlapping interests, EMBO J., 23, 4709, 10.1038/sj.emboj.7600481 Cam, 2003, Emerging roles for E2F: beyond the G1/S transition and DNA replication, Cancer Cell, 3, 311, 10.1016/S1535-6108(03)00080-1 Dimova, 2005, The E2F transcriptional network: old acquaintances with new faces, Oncogene, 24, 2810, 10.1038/sj.onc.1208612 Nevins, 2001, The Rb/E2F pathway and cancer, Hum. Mol. Genet., 10, 699, 10.1093/hmg/10.7.699 Adams, 1995, Transcriptional control by E2F, Semin. Cancer Biol., 6, 99, 10.1006/scbi.1995.0013 Yoshida, 2004, Regulation of Geminin and Cdt1 expression by E2F transcription factors, Oncogene, 23, 3802, 10.1038/sj.onc.1207488 Yoshida, 2004, Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor, Oncogene, 23, 6250, 10.1038/sj.onc.1207829 Walker, 2001, Drug target discovery by gene expression analysis: cell cycle genes, Curr. Cancer Drug Targets, 1, 73, 10.2174/1568009013334241 Osborne, 1994, Nuf2, a spindle pole body-associated protein required for nuclear division in yeast, J. Cell Biol., 125, 853, 10.1083/jcb.125.4.853 DeLuca, 2002, hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells, J. Cell Biol., 159, 549, 10.1083/jcb.200208159 Ayad, 2003, Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC, Cell, 113, 101, 10.1016/S0092-8674(03)00232-0 Rankin, 2005, Sororin, a substrate of the anaphase-promoting complex, is required for sister chromatid cohesion in vertebrates, Mol. Cell, 18, 185, 10.1016/j.molcel.2005.03.017 Gassmann, 2004, Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle, J. Cell Biol., 166, 179, 10.1083/jcb.200404001 Prescott, 2001, A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation, J. Biol. Chem., 276, 48276, 10.1074/jbc.M107357200 Haggerty, 2003, A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites, Proc. Natl. Acad. Sci. U. S. A., 100, 5313, 10.1073/pnas.0931346100 Osthus, 2005, The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo, Cancer Res., 65, 5620, 10.1158/0008-5472.CAN-05-0536 Huang, 2005, Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells, Cancer Res., 65, 5607, 10.1158/0008-5472.CAN-05-0500 Pelengaris, 2002, c-MYC: more than just a matter of life and death, Nat. Rev., Cancer, 2, 764, 10.1038/nrc904 Dang, 1999, c-Myc target genes involved in cell growth, apoptosis, and metabolism, Mol. Cell. Biol., 19, 1, 10.1128/MCB.19.1.1 Santoni-Rugiu, 2000, Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway, Mol. Cell. Biol., 20, 3497, 10.1128/MCB.20.10.3497-3509.2000 Aguda, 2003, A structural analysis of the qualitative networks regulating the cell cycle and apoptosis, Cell Cycle, 2, 538, 10.4161/cc.2.6.550 Matsumura, 2003, E2F1 and c-Myc in cell growth and death, Cell Cycle, 2, 333, 10.4161/cc.2.4.428 Leone, 2001, Myc requires distinct E2F activities to induce S phase and apoptosis, Mol. Cell, 8, 105, 10.1016/S1097-2765(01)00275-1 Blackwell, 1990, Sequence-specific DNA binding by the c-Myc protein, Science, 250, 1149, 10.1126/science.2251503 Eisenman, 2001, Deconstructing myc, Genes Dev., 15, 2023, 10.1101/gad928101 Cole, 1999, The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation, Oncogene, 18, 2916, 10.1038/sj.onc.1202748 Grandori, 1997, Myc target genes, Trends Biochem. Sci., 22, 177, 10.1016/S0968-0004(97)01025-6 Grandori, 2000, The Myc/Max/Mad network and the transcriptional control of cell behavior, Annu. Rev. Cell Dev. Biol., 16, 653, 10.1146/annurev.cellbio.16.1.653 Hermeking, 2003, The MYC oncogene as a cancer drug target, Curr. Cancer Drug Targets, 3, 163, 10.2174/1568009033481949 Lutz, 2002, Contributions of Myc to tumorigenesis, Biochim. Biophys. Acta, 1602, 61 Bartek, 2001, Pathways governing G1/S transition and their response to DNA damage, FEBS Lett., 490, 117, 10.1016/S0014-5793(01)02114-7 DeGregori, 2002, The genetics of E2F family of transcription factors: shared functions and unique roles, Biochim. Biophys. Acta, 1620, 131 Slansky, 1996, Introduction to the E2F family: protein structure and gene regulation, Curr. Top. Microbiol. Immunol., 208, 1 Harbour, 2000, The Rb/E2F pathway: expanding roles and emerging paradigms, Genes Dev., 14, 2393, 10.1101/gad.813200 Lukas, 1996, Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression, Mol. Cell. Biol., 16, 1047, 10.1128/MCB.16.3.1047 DeGregori, 1997, Distinct roles for E2F proteins in cell growth control and apoptosis, Proc. Natl. Acad. Sci. U. S. A., 94, 7245, 10.1073/pnas.94.14.7245 Trimarchi, 2002, Sibling rivalry in the E2F family, Nat. Rev., Mol. Cell Biol., 3, 11, 10.1038/nrm714 Chen, 2005, R1, a novel repressor of the human monoamine oxidase A, J. Biol. Chem., 280, 11552, 10.1074/jbc.M410033200 Amati, 1998, Myc and the cell cycle, Front. Biosci., 3, 250, 10.2741/A239 Johnson, 1993, Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature, 13, 349, 10.1038/365349a0 Vigo, 1999, CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase, Mol. Cell. Biol., 19, 6379, 10.1128/MCB.19.9.6379 Obaya, 1999, Mysterious liaisons: the relationship between c-Myc and the cell cycle, Oncogene, 18, 2934, 10.1038/sj.onc.1202749 Santoni-Rugiu, 2002, E2F activity is essential for survival of Myc-overexpressing human cancer cells, Oncogene, 21, 6498, 10.1038/sj.onc.1205828 Tanaka, 2002, E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination, Mol. Cell, 9, 1017, 10.1016/S1097-2765(02)00522-1 Eischen, 2001, Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1, Oncogene, 20, 6983, 10.1038/sj.onc.1204892 Perez-Roger, 1997, Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes, Oncogene, 14, 2373, 10.1038/sj.onc.1201197 Ohtani, 1995, Regulation of the cyclin E gene by transcription factor E2F1, Proc. Natl. Acad. Sci. U. S. A., 92, 12146, 10.1073/pnas.92.26.12146 Galaktionov, 1996, Cdc25 cell-cycle phosphatase as a target of c-myc, Nature, 382, 511, 10.1038/382511a0 McMahon, 1998, The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins, Cell, 94, 363, 10.1016/S0092-8674(00)81479-8